Previous study has reported an increase in the expression of MT (MT1E, MT1F, MT1G, MT1H, MT1M, MT1X and MT2A) in the substantia nigra and frontal cortex of PD patients (Michael et al., 2011). Here, MT2A is linked to Parkinson disease.